Open AccessTransactivation of the TIEG1 confers growth inhibition of transforming growth factor-β-susceptible hepatocellular carcinoma cells
Author(s) -
Lei Jiang,
YiuKay Lai,
Jinfang Zhang,
Cerise YuenKi Chan,
Gang Lǚ,
Marie C.M. Lin,
MingLiang He,
Jicheng Li,
HsiangFu Kung
Publication year - 2012
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v18.i17.2035
Subject(s) - stathmin , cancer research , cell culture , cell growth , transforming growth factor , transactivation , transfection , small interfering rna , growth inhibition , microbiology and biotechnology , chemistry , viability assay , mtt assay , biology , gene expression , gene , phosphorylation , biochemistry , genetics
To investigate the role of transforming growth factor (TGF)-β-inducible early gene 1 (TIEG1) in TGF-β-induced growth inhibition in hepatocellular carcinoma (HCC) cells.